Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. (Q51896431)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2007

Language	Label	Description	Also known as
English	Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.	scientific article published in January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

Alexandra Boer Kimball

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dennis A Revicki

1

object named as

Dennis A Revicki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Mary Kaye Willian

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alan Menter

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kenneth B Gordon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Craig L Leonardi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Richard G Langley

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Miriam Kimel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Martin Okun

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Journal of Dermatological Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

341-350

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Quality of life assessments in dermatology

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

The impact of psoriasis on psychosocial life domains. A review

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

A randomized trial of etanercept as monotherapy for psoriasis.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

10 years experience of the Dermatology Life Quality Index (DLQI).

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Responsiveness and minimal important differences for patient reported outcomes

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Identifiers

10.1080/09546630701646172

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51896431&oldid=2152126954"